Caris Life Sciences Climbs 3.99% on Strong Q4, Outperforming Peers Amid Energy Expansion
Caris Life Sciences hits $32, up 3.99% as investors spot growing pipeline momentum and solid market cap.
- CARIS LIFE SCIENCES INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read


